{"id":"W4255815021","doi":"10.1200/jco.2011.29.7_suppl.3","title":"A phase III randomized trial comparing intermittent versus continuous androgen suppression for patients with PSA progression after radical therapy: NCIC CTG PR.7/SWOG JPR.7/CTSU JPR.7/UK Intercontinental Trial CRUKE/01/013.","year":2011,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Androgen deprivation therapy; Clinical endpoint; Prostate cancer; Interim analysis; Internal medicine; Randomized controlled trial; Goserelin; Androgen suppression; Prostatectomy; Urology; Placebo; Progression-free survival; Androgen; Oncology; Cancer; Chemotherapy; Hormone","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002793685,0.002055639,0.002913495,0.0006344084,0.0005966082,0.001261668,0.00141358,0.002288388,0.0130341],"category_scores_gemma":[0.003029281,0.0005752863,0.002613624,0.0006541873,0.001341364,0.001070448,0.0005957278,0.00396323,0.001442837],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001001908,"about_ca_system_score_gemma":0.001923571,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001621558,"about_ca_topic_score_gemma":0.003883311,"domain_scores_codex":[0.9989681,0.0006624696,0.00004872957,0.0001445601,0.00005503655,0.0001211389],"domain_scores_gemma":[0.9978257,0.0007605715,0.0004926077,0.0001601713,0.0001038659,0.0006571752],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9909552,0.002951912,0.0001882368,0.0002889486,0.000357668,0.00001271212,0.0000197022,0.0001250376,0.0005367709,0.00007149087,0.0005214113,0.003970905],"study_design_scores_gemma":[0.9676379,0.03102162,0.0004584568,0.0000210908,0.0001938372,0.00001162928,0.000009582199,0.0001522418,0.00007322588,0.0001010326,0.0003126654,0.000006701809],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9553318,0.007256675,0.001373264,0.002219225,0.001974219,0.02081928,0.004167601,0.0002801948,0.006577831],"genre_scores_gemma":[0.9578205,0.002514447,0.003543028,0.003059927,0.001033164,0.02140806,0.002812158,0.00006749031,0.007741231],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0130341,"threshold_uncertainty_score":0.04360342,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1550202324802234,"score_gpt":0.4819053568972396,"score_spread":0.3268851244170162,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}